The impact of glioblastoma heterogeneity on preclinical studies and treatment response – Dr Rasha Rezk (University of Cambridge)

When:
February 5, 2021 @ 2:30 pm – 3:00 pm
2021-02-05T14:30:00+00:00
2021-02-05T15:00:00+00:00
Where:
Zoom Meeting ID: 819 1682 8857
Contact:
Hilde Hambro

Abstract not available

Leave a Reply

Your email address will not be published. Required fields are marked *